期刊文献+

应重视肝细胞癌的规范化治疗 被引量:1

Pay attention to standardized treatment of hepatocellular carcinoma
原文传递
导出
摘要 肝细胞癌(简称肝癌)是威胁我国人民群众身体健康的严重疾病。尽管肝癌治疗方式多样,但总体疗效仍不令人满意。规范化治疗是改善肝癌患者预后的重要保障,本文对肝癌规范化治疗的重要性做一简要述评,提出规范的分期是制定合理治疗方案的前提,规范的病理学诊断是综合治疗的基础,规范的治疗方式是保证肝癌疗效的关键,多学科协作团队是规范化治疗的组织保证。 Hepatocellular carcinoma is a serious disease that threatens the health of Chinese people.At present,various treatments for hepatocellular carcinoma have their own advantages and disadvantages,which are suitable for its specific individual patient.This article makes a brief review about the importance of standardized treatment for hepatocellular carcinoma.Meanwhile,it should be noticed that standardized staging system is the prerequisite for making a reasonable treatment plan,standardized pathological diagnosis is the basis of comprehensive treatment,standardized treatment is the key to the efficacy,and the multidisciplinary team is the organizational basis for standardized treatment.
作者 毕新宇 蔡建强 Bi Xinyu;Cai Jianqiang(Department of Hepatobiliary Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)
机构地区 国家癌症中心
出处 《中华外科杂志》 CAS CSCD 北大核心 2021年第10期812-815,共4页 Chinese Journal of Surgery
基金 深圳市“医疗卫生三名工程”(SZS M202011010) 北京市希思科临床肿瘤学研究基金会(Y-XD202001-0111)。
关键词 肝肿瘤 外科手术 Liver neoplasms Surgical procedures,operative
  • 相关文献

参考文献3

二级参考文献67

  • 1无.原发性肝癌诊疗规范(2019年版)[J].肝癌电子杂志,2020(1):5-23. 被引量:40
  • 2Di-Yang Xie,Zheng-Gang Ren,Jian Zhou,Jia Fan,Qiang Gao.2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights[J].Hepatobiliary Surgery and Nutrition,2020,9(4):452-463. 被引量:85
  • 3Tianfu Wen,Chen Jin,Antonio Facciorusso,Matteo Donadon,Ho-Seong Han,Yilei Mao,Chaoliu Dai,Shuqun Cheng,Bixiang Zhang,Baogang Peng,Shunda Du,Changjun Jia,Feng Xu,Jie Shi,Juxian Sun,Peng Zhu,Satoshi Nara,JMichael Millis,Qiu Li,Weixia Chen,Wusheng Lu,Hong Tang,Lvnan Yan,Yong Zeng,Bo Li,Jiayin Yang,Wentao Wang,Hong Wu,Mingqing Xu,Zheyu Chen,Changli Lu,Chuan Li,Wei Peng,Xiaoyun Zhang.Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus[J].Hepatobiliary Surgery and Nutrition,2018,7(5):353-371. 被引量:41
  • 4吴孟超.应重视小肝癌的诊断与治疗[J].中华医学杂志,2007,87(30):2089-2091. 被引量:11
  • 5Koh C, Zhao X, Samala N, et al. AASLD clinical practice guide- lines: a critical review of scientific evidence and evolving reco- mmendations[J]. Hepatology, 2013, 58(6): 2142-2152.
  • 6William H, Ralph H, Timothy H, et al. Surgical pathology dissec- tion: an illustrated guide[ M]. New York:Springer, 2003:7-9.
  • 7Bass BP, Engel KB, Greytak SR, et al. A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin- embedded ( FFPE ) tissue : how well do you know your FFPE specimen? [ J]. Arch Pathol Lab Med, 2014, 138(11): 1520-1530.
  • 8Lu XY, Xi T, Lau WY, et al. Hepatoeellular carcinoma expres- sing cholangiocyte phenotype is a novel subtype with highly aggressive behavior [ J ]. Ann Surg Oncol, 2011, 18 ( 8 ) : 2210-2217.
  • 9Cai SW, Yang SZ, Gao J, et al. Prognostic significance of mast cell count following curative resection for pancreatic ductal adeno- carcinoma[ J ]. Surgery, 201 l, 149 (4) : 576-584.
  • 10应越英.肝细胞肝癌的病理学//汤钊猷,主编.原发性肝癌[M].上海:上海科学技术出版社,1981:115-146.

共引文献342

同被引文献8

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部